These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 26446603)

  • 21. HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.
    Nitschke K; Barriga A; Schmidt J; Timm J; Viazov S; Kuntzen T; Kim AY; Lauer GM; Allen TM; Gaudieri S; Rauch A; Lange CM; Sarrazin C; Eiermann T; Sidney J; Sette A; Thimme R; López D; Neumann-Haefelin C
    J Hepatol; 2014 Jan; 60(1):22-9. PubMed ID: 23978718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.
    Schmidt J; Iversen AK; Tenzer S; Gostick E; Price DA; Lohmann V; Distler U; Bowness P; Schild H; Blum HE; Klenerman P; Neumann-Haefelin C; Thimme R
    PLoS Pathog; 2012; 8(11):e1003042. PubMed ID: 23209413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.
    Timm J; Li B; Daniels MG; Bhattacharya T; Reyor LL; Allgaier R; Kuntzen T; Fischer W; Nolan BE; Duncan J; Schulze zur Wiesch J; Kim AY; Frahm N; Brander C; Chung RT; Lauer GM; Korber BT; Allen TM
    Hepatology; 2007 Aug; 46(2):339-49. PubMed ID: 17559151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3.
    Giugliano S; Oezkan F; Bedrejowski M; Kudla M; Reiser M; Viazov S; Scherbaum N; Roggendorf M; Timm J
    Hepatology; 2009 Sep; 50(3):707-16. PubMed ID: 19637188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors.
    Zhang H; Zhang J; Chen L; Weng Z; Tian Y; Zhao H; Li Y; Chen L; Liang Z; Zheng H; Zhao W; Zhong S; Li Y
    J Gen Virol; 2017 Mar; 98(3):374-384. PubMed ID: 27902325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition.
    Wang H; Eckels DD
    J Immunol; 1999 Apr; 162(7):4177-83. PubMed ID: 10201944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site.
    Neumann-Haefelin C; Killinger T; Timm J; Southwood S; McKinney D; Blum HE; Thimme R
    J Gen Virol; 2007 Jul; 88(Pt 7):1986-1991. PubMed ID: 17554032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus.
    Eckels DD; Zhou H; Bian TH; Wang H
    Int Immunol; 1999 Apr; 11(4):577-83. PubMed ID: 10323211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.
    Dazert E; Neumann-Haefelin C; Bressanelli S; Fitzmaurice K; Kort J; Timm J; McKiernan S; Kelleher D; Gruener N; Tavis JE; Rosen HR; Shaw J; Bowness P; Blum HE; Klenerman P; Bartenschlager R; Thimme R
    J Clin Invest; 2009 Feb; 119(2):376-86. PubMed ID: 19139562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
    Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.
    Prabdial-Sing N; Puren AJ; Bowyer SM
    BMC Immunol; 2012 Dec; 13():67. PubMed ID: 23227878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele.
    Antunes DA; Rigo MM; Silva JP; Cibulski SP; Sinigaglia M; Chies JA; Vieira GF
    Mol Immunol; 2011 Jul; 48(12-13):1461-7. PubMed ID: 21513985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ; Wang WL; Wang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.
    Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P
    J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERAP1 allotypes shape the epitope repertoire of virus-specific CD8
    Kemming J; Reeves E; Nitschke K; Widmeier V; Emmerich F; Hermle T; Gostick E; Walker A; Timm J; Price DA; Hofmann M; Thimme R; James E; Neumann-Haefelin C
    J Hepatol; 2019 Jun; 70(6):1072-1081. PubMed ID: 30769005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase.
    Oniangue-Ndza C; Kuntzen T; Kemper M; Berical A; Wang YE; Neumann-Haefelin C; Foote PK; Hills-Evans K; Reyor LL; Kane K; Gladden AD; Bloom AK; Power KA; Thimme R; Lauer GM; Henn MR; Kim AY; Allen TM
    J Virol; 2011 Nov; 85(22):11883-90. PubMed ID: 21880756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of CD4
    Lucas M; Deshpande P; James I; Rauch A; Pfafferott K; Gaylard E; Merani S; Plauzolles A; Lucas A; McDonnell W; Kalams S; Pilkinton M; Chastain C; Barnett L; Prosser A; Mallal S; Fitzmaurice K; Drummer H; Ansari MA; Pedergnana V; Barnes E; John M; Kelleher D; Klenerman P; Gaudieri S
    Sci Rep; 2018 May; 8(1):7224. PubMed ID: 29740042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa.
    Prabdial-Sing N; Blackard JT; Puren AJ; Mahomed A; Abuelhassan W; Mahlangu J; Vermeulen M; Bowyer SM
    Antiviral Res; 2016 Mar; 127():90-8. PubMed ID: 26704023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.